Oncology & Cancer

New findings provide hope for treatment of multiple myeloma

Researchers at Karolinska Institutet have investigated the use of low dose venetoclax, an experimental drug, for the treatment of the heterogeneous cancer disease multiple myeloma in patients who had relapsed on standard ...

Oncology & Cancer

New method predicts childhood hyperdiploid B-ALL relapse risk

An international research team coordinated by Dr. Oscar Molina and Dr. Pablo Menéndez, from the Josep Carreras Leukaemia Research Institute, identifies chromosomal abnormalities associated with relapse in a frequent subset ...

Oncology & Cancer

In prostate cancer prognosis, telomere length may matter

Like the plastic caps at the end of shoelaces, telomeres protect—in their case—the interior-gene containing parts of chromosomes that carry a cell's instructional material. Cancer cells are known to have short telomeres, ...

page 7 from 13